These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8596599)

  • 21. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.
    Wikler A
    Adv Biochem Psychopharmacol; 1973; 8(0):399-414. PubMed ID: 4795072
    [No Abstract]   [Full Text] [Related]  

  • 22. Cocaine abuse: a review of current and experimental treatments.
    Kleber HD; Gawin FH
    NIDA Res Monogr; 1984; 50():111-29. PubMed ID: 6440022
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of cocaine abuse in methadone maintenance programs.
    Kolar AF
    Md Med J; 1989 Dec; 38(12):1067-8. PubMed ID: 2615578
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans.
    Walsh SL; Sullivan JT; Preston KL; Garner JE; Bigelow GE
    J Pharmacol Exp Ther; 1996 Nov; 279(2):524-38. PubMed ID: 8930154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 28. Methadone maintenance and its implication for theories of narcotic addiction.
    Dole VP; Nyswander ME
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():359-66. PubMed ID: 5723803
    [No Abstract]   [Full Text] [Related]  

  • 26. Antagonists to the battle.
    DiPalma JR
    RN; 1976 Nov; 39(11):95-6, 98. PubMed ID: 1049452
    [No Abstract]   [Full Text] [Related]  

  • 27. Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment.
    Ellinwood EH; Lee TH
    NIDA Res Monogr; 1997; 175():192-207. PubMed ID: 9467799
    [No Abstract]   [Full Text] [Related]  

  • 28. Medications development: successes and challenges.
    Vocci F; Ling W
    Pharmacol Ther; 2005 Oct; 108(1):94-108. PubMed ID: 16083966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological treatments for substance use disorders.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2004 Aug; 42(8):14-20. PubMed ID: 15354595
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence-based treatment of geriatric substance abuse.
    Oslin DW
    Psychiatr Clin North Am; 2005 Dec; 28(4):897-911, ix. PubMed ID: 16325734
    [No Abstract]   [Full Text] [Related]  

  • 31. A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency.
    Jenkins SW; Warfield NA; Blaine JD; Cornish J; Ling W; Rosen MI; Urschel H; Wesson D; Ziedonis D
    Psychopharmacol Bull; 1992; 28(1):21-6. PubMed ID: 1609038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid opiate detoxification. Assessment is needed to exclude certain patients before detoxification.
    Rumball D; Williams J
    BMJ; 1997 Sep; 315(7109):682. PubMed ID: 9310588
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation and clinical management of cocaine abusers.
    Millman RB
    J Clin Psychiatry; 1988 Feb; 49 Suppl():27-33. PubMed ID: 3276671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spectrum of cocaine abuse and its treatment.
    Kleber HD; Gawin FH
    J Clin Psychiatry; 1984 Dec; 45(12 Pt 2):18-23. PubMed ID: 6438067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International Narcotics Research Conference (INRC) 2006.
    Chavkin C
    IDrugs; 2006 Oct; 9(10):693-5. PubMed ID: 17016774
    [No Abstract]   [Full Text] [Related]  

  • 36. Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research.
    Kreek MJ
    NIDA Res Monogr; 1997; 175():5-35. PubMed ID: 9467791
    [No Abstract]   [Full Text] [Related]  

  • 37. A history of the development of narcotic antagonists for the treatment of narcotic addiction.
    Martin WR
    NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106
    [No Abstract]   [Full Text] [Related]  

  • 38. Outcome measurement considerations: pharmacological treatments for substance abuse.
    Moras K
    NIDA Res Monogr; 1997; 175():118-36. PubMed ID: 9467795
    [No Abstract]   [Full Text] [Related]  

  • 39. Behavioral pharmacology of narcotic antagonists.
    Mello NK
    NIDA Res Monogr; 1978; (19):126-41. PubMed ID: 218104
    [No Abstract]   [Full Text] [Related]  

  • 40. Narcotic antagonists: another approach to addiction therapy.
    Fink M; Freedman AM; Zaks AM; Resnick RB
    Am J Nurs; 1971 Jul; 71(7):1359-63. PubMed ID: 5207098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.